About Caitlyn
Caitlyn Krebs is the Co-founder and CEO of Nalu Bio, a biotech company creating chemistry-based, ultra-pure cannabinoids. With over 20 years of experience in the life sciences industry, she has led startups in complex fields such as cancer genomics, digital health for Alzheimer's, and pre-diabetes. At Nalu Bio, Caitlyn applies a pharmaceutical-grade approach to the cannabinoid industry, focusing on quality, consistency, and purity for both B2B ingredients and therapeutic drug development. She successfully led the company through its $12 million Series A financing.
On the podcast with Caitlyn
Add Caitlyn to your advisory board
Jason personally tees up the warm intro when there's a clear fit. Tell him what you're working on and why Caitlyn's perspective would move it forward.